LuciOsim is used in treating EGFR mutation-positive non-small cell lung cancer. It is widely used for advanced stages.
Active Ingredient
Osimertinib is an EGFR tyrosine kinase inhibitor.
Uses of LuciOsim
• EGFR-positive NSCLC
• Metastatic lung cancer
How LuciOsim Works
It blocks EGFR mutations responsible for cancer cell growth.
How to Use LuciOsim
• Take once daily
• With or without food
Possible Side Effects
• Diarrhea
• Rash
• Nail toxicity
Precautions
• Monitor heart and lungs
• Avoid pregnancy
Safety Information
Requires regular monitoring.
Storage
• Store at room temperature
• Keep away from moisture
• Keep out of reach of children
